Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillation

Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE−/− mice

(2018) Marcello Rattazzi et al.   Cardiovascular Therapeutics

Should we still be utilizing warfarin in the type 2 diabetic patient?

(2018) David S. H. Bell et al.   DIABETES OBESITY & METABOLISM

Non-vitamin K Antagonist Oral Anticoagulants vs. Warfarin at Risk of Fractures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2018) Zhi-Chun Gu et al.   Frontiers in Pharmacology

Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting

(2018) Silvia Lee et al.   Cardiovascular Diabetology

Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study

(2017) Sofia Dahlqvist et al.   Lancet Diabetes & Endocrinology

Atrial Fibrillation, Type 2 Diabetes, and Non–Vitamin K Antagonist Oral Anticoagulants

(2017) Anna Plitt et al.   JAMA Cardiology

International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation

(2015) Winnie W. Nelson et al.   American Journal of Cardiovascular Drugs

Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?

(2015) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Defining the Role of Oxidative Stress in Atrial Fibrillation and Diabetes

(2014) MARK T. ZIOLO et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis

(2013) C. K. Kramer et al.   BMJ-British Medical Journal

Impaired drug-binding capacities of in vitro and in vivo glycated albumin

(2012) Jennifer Baraka-Vidot et al.   BIOCHIMIE

Vitamin K-Antagonists Accelerate Atherosclerotic Calcification and Induce a Vulnerable Plaque Phenotype

(2012) Leon J. Schurgers et al.   PLoS One

Potential Clinical Utility of Advanced Glycation End Product Cross-Link Breakers in Age- and Diabetes-Associated Disorders

(2012) Sho-ichi Yamagishi   REJUVENATION RESEARCH

Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial Fibrillation

(2011) Rachel R. Huxley et al.   AMERICAN JOURNAL OF CARDIOLOGY

Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients

(2011) B. Weijs et al.   EUROPEAN HEART JOURNAL

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)

(2010) Danielle E Smith et al.   BMC Cardiovascular Disorders

Relationships between undercarboxylated osteocalcin and vitamin K intakes, bone turnover, and bone mineral density in healthy women

(2010) Mika Yamauchi et al.   CLINICAL NUTRITION

Vitamin K supplementation and progression of coronary artery calcium in older men and women

(2009) M Kyla Shea et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION